JP2017518276A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017518276A5 JP2017518276A5 JP2016565402A JP2016565402A JP2017518276A5 JP 2017518276 A5 JP2017518276 A5 JP 2017518276A5 JP 2016565402 A JP2016565402 A JP 2016565402A JP 2016565402 A JP2016565402 A JP 2016565402A JP 2017518276 A5 JP2017518276 A5 JP 2017518276A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrazolo
- pyrimidin
- fluoro
- phenyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*(C1*)C=*C2=C1C(c(c(C)c1)ccc1Oc1c(*)c(C)c(*)c(*)c1*)=**2*C(*)=O Chemical compound C*(C1*)C=*C2=C1C(c(c(C)c1)ccc1Oc1c(*)c(C)c(*)c(*)c1*)=**2*C(*)=O 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410175783.7 | 2014-04-29 | ||
| CN201410175783.7A CN105017256A (zh) | 2014-04-29 | 2014-04-29 | 多氟化合物作为布鲁顿酪氨酸激酶抑制剂 |
| PCT/CN2015/000290 WO2015165279A1 (zh) | 2014-04-29 | 2015-04-27 | 多氟化合物作为布鲁顿酪氨酸激酶抑制剂 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019220363A Division JP7005582B2 (ja) | 2014-04-29 | 2019-12-05 | ブルトン型チロシンキナーゼ（ｂｔｋ）インヒビターとしての多フルオロ置換化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017518276A JP2017518276A (ja) | 2017-07-06 |
| JP2017518276A5 true JP2017518276A5 (https=) | 2018-06-14 |
| JP6670756B2 JP6670756B2 (ja) | 2020-03-25 |
Family
ID=54358137
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016565402A Active JP6670756B2 (ja) | 2014-04-29 | 2015-04-27 | ブルトン型チロシンキナーゼ（ｂｔｋ）インヒビターとしての多フルオロ置換化合物 |
| JP2019220363A Active JP7005582B2 (ja) | 2014-04-29 | 2019-12-05 | ブルトン型チロシンキナーゼ（ｂｔｋ）インヒビターとしての多フルオロ置換化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019220363A Active JP7005582B2 (ja) | 2014-04-29 | 2019-12-05 | ブルトン型チロシンキナーゼ（ｂｔｋ）インヒビターとしての多フルオロ置換化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9532990B2 (https=) |
| EP (1) | EP3138842B1 (https=) |
| JP (2) | JP6670756B2 (https=) |
| KR (2) | KR20160144378A (https=) |
| CN (3) | CN105017256A (https=) |
| AU (1) | AU2015252654C1 (https=) |
| BR (1) | BR112016025132A2 (https=) |
| CA (1) | CA2947338C (https=) |
| EA (2) | EA037227B1 (https=) |
| ES (1) | ES2857251T3 (https=) |
| IL (1) | IL248546B (https=) |
| MX (2) | MX387487B (https=) |
| WO (1) | WO2015165279A1 (https=) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015008844A1 (ja) | 2013-07-18 | 2015-01-22 | 大鵬薬品工業株式会社 | Ｆｇｆｒ阻害剤耐性癌の治療薬 |
| TR201907147T4 (tr) | 2013-07-18 | 2019-06-21 | Taiho Pharmaceutical Co Ltd | Fgfr inhibitörünün aralıklı uygulanmasına yönelik anti-tümör ilaç. |
| CN105017256A (zh) * | 2014-04-29 | 2015-11-04 | 浙江导明医药科技有限公司 | 多氟化合物作为布鲁顿酪氨酸激酶抑制剂 |
| EP3221320A4 (en) * | 2014-11-19 | 2018-04-25 | Sun Pharmaceutical Industries Ltd | A process for the preparation of ibrutinib |
| US10214532B2 (en) | 2015-02-12 | 2019-02-26 | Shanghai Dude Medical Science and Technology Co., Ltd. | Process for preparing ibrutinib |
| CN106146508A (zh) * | 2015-03-19 | 2016-11-23 | 浙江导明医药科技有限公司 | 优化的联合用药及其治疗癌症和自身免疫疾病的用途 |
| US9717745B2 (en) | 2015-03-19 | 2017-08-01 | Zhejiang DTRM Biopharma Co. Ltd. | Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases |
| CN106146511A (zh) * | 2015-04-03 | 2016-11-23 | 安润医药科技（苏州）有限公司 | 吡唑并嘧啶衍生物、制备方法、药物组合物及用途 |
| CN106146512B (zh) * | 2015-04-09 | 2018-07-17 | 北京睿创康泰医药研究院有限公司 | 依鲁替尼的制备方法 |
| CA2981886A1 (en) | 2015-04-16 | 2016-10-20 | Icahn School Of Medicine At Mount Sinai | Ksr antagonists |
| EP3424505A4 (en) | 2016-03-04 | 2019-10-16 | Taiho Pharmaceutical Co., Ltd. | PREPARATION AND COMPOSITION FOR THE TREATMENT OF MALIGNANT TUMORS |
| US11883404B2 (en) | 2016-03-04 | 2024-01-30 | Taiho Pharmaceuticals Co., Ltd. | Preparation and composition for treatment of malignant tumors |
| JP6959252B2 (ja) | 2016-03-24 | 2021-11-02 | ミッション セラピューティクス リミティド | Ｄｕｂ阻害剤としての１−シアノピロリジン誘導体 |
| WO2018002958A1 (en) | 2016-06-30 | 2018-01-04 | Sun Pharma Advanced Research Company Limited | Novel hydrazide containing compounds as btk inhibitors |
| CN106146518A (zh) * | 2016-06-30 | 2016-11-23 | 苏州爱玛特生物科技有限公司 | 一种布鲁顿酪氨酸激酶抑制剂中间体及其制备方法 |
| GB201616511D0 (en) | 2016-09-29 | 2016-11-16 | Mission Therapeutics Limited | Novel compounds |
| JP6782855B2 (ja) * | 2016-11-15 | 2020-11-11 | 杭州和正医薬有限公司 | 選択性ブルトン型チロシンキナーゼ阻害剤及びその使用 |
| MA46995A (fr) | 2016-12-03 | 2019-10-09 | Acerta Pharma Bv | Méthodes et compositions pour l'utilisation de lymphocytes t thérapeutiques en association avec des inhibiteurs de kinase |
| CN106831788B (zh) * | 2017-01-22 | 2020-10-30 | 鲁南制药集团股份有限公司 | 伊布替尼精制方法 |
| KR102627756B1 (ko) | 2017-03-22 | 2024-01-23 | 쑤저우 바이지부공 파마수티컬 테크널러지 컴퍼니 리미티드 | 브루톤 타이로신 키나제 억제제 |
| CN107501270B (zh) * | 2017-09-01 | 2019-06-28 | 宏腾建设集团有限公司 | 一种含有磺酰吖丙啶结构的化合物、药物组合物以及其应用 |
| TW201922256A (zh) | 2017-10-27 | 2019-06-16 | 中國大陸商浙江導明醫藥科技有限公司 | 治療淋巴樣惡性疾病之方法 |
| CN109970740A (zh) * | 2017-12-27 | 2019-07-05 | 广东众生药业股份有限公司 | 4-氨基-嘧啶并氮杂环衍生物及其制备方法和用途 |
| SG11202008435SA (en) | 2018-03-19 | 2020-10-29 | Taiho Pharmaceutical Co Ltd | Pharmaceutical composition including sodium alkyl sulfate |
| CN110964016B (zh) | 2018-09-29 | 2021-05-28 | 南京药捷安康生物科技有限公司 | 氨基降茨烷衍生物及其制备方法与应用 |
| CN113260618A (zh) * | 2018-11-09 | 2021-08-13 | 大鹏药品工业株式会社 | 二甲氧基苯化合物类似物、分析所述化合物的方法和所述化合物的标准品 |
| CN111171035B (zh) * | 2018-11-13 | 2021-03-30 | 山东大学 | 4-苯氧基苯基吡唑并嘧啶酰胺衍生物的制备方法和应用 |
| CN111454268B (zh) * | 2019-01-18 | 2023-09-08 | 明慧医药（上海）有限公司 | 作为布鲁顿酪氨酸激酶抑制剂的环状分子 |
| CA3133184A1 (en) | 2019-03-15 | 2020-09-24 | Bayer Aktiengesellschaft | Specifically substituted 3-phenyl-5-spirocyclopentyl-3-pyrrolin-2-ones and their use as herbicides |
| US20220143049A1 (en) | 2019-03-21 | 2022-05-12 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| CA3139285A1 (en) * | 2019-06-27 | 2020-12-30 | Hangzhou Healzen Therapeutics Co., Ltd. | Casein kinase 1e inhibitor, pharmaceutical composition and application thereof |
| WO2021038540A1 (en) | 2019-08-31 | 2021-03-04 | Sun Pharma Advanced Research Company Limited | Cycloalkylidene carboxylic acids and derivatives as btk inhibitors |
| HUE065965T2 (hu) * | 2019-09-26 | 2024-06-28 | Jumbo Drug Bank Co Ltd | 4-fluor-1H-pyrazolo[3,4-C]piridin-származékok mint szelektív bruton-tirozinkináz (BTK) inhibitorok a B-sejtes limfóma és autoimmun betegségek kezelésére |
| EP4054579A1 (en) | 2019-11-08 | 2022-09-14 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| TW202144465A (zh) | 2020-02-11 | 2021-12-01 | 瑞士商諾和席卓股份有限公司 | 合成聚葡萄胺糖衍生物之新方法及其用途 |
| EP3865535A1 (en) | 2020-02-11 | 2021-08-18 | Bosti Trading Ltd. | New method of synthesis of chitosan derivatives and uses thereof |
| AU2020436612A1 (en) * | 2020-03-16 | 2022-09-01 | Flash Therapeutics, Llc | Compounds for treating or inhibiting recurrence of acute myeloid leukemia |
| MX2022015495A (es) | 2020-06-08 | 2023-03-14 | Halia Therapeutics Inc | Inhibidores de cinasa relacionada con el gen a nunca en mitosis (nek7). |
| CN113943294A (zh) * | 2020-07-15 | 2022-01-18 | 成都海博为药业有限公司 | 一种作为btk抑制剂的化合物及其制备方法与用途 |
| WO2022081512A1 (en) * | 2020-10-12 | 2022-04-21 | Synubi Pharmaceuticals Llc | Compositions and methods of treatment of neuroinflammatory diseases with bruton's tyrosine kinase inhibitors |
| CN112574046A (zh) * | 2020-12-17 | 2021-03-30 | 深圳市华先医药科技有限公司 | 一种制备(1r,3s)-3-氨基环戊醇盐酸盐的方法 |
| US20240100172A1 (en) | 2020-12-21 | 2024-03-28 | Hangzhou Jijing Pharmaceutical Technology Limited | Methods and compounds for targeted autophagy |
| WO2022137240A1 (en) * | 2020-12-23 | 2022-06-30 | Yeda Research And Development Co. Ltd. | Methacrylamides protein binders and uses thereof |
| ES3010513T3 (en) * | 2021-02-03 | 2025-04-03 | Accutar Biotechnology Inc | Substituted pyrrolopyrimidine and pyrazolopyrimidine as bruton's tyrosine kinase (btk) degraders |
| AR126678A1 (es) | 2021-08-06 | 2023-11-01 | Novochizol Sa | Composiciones para el cuidado de las plantas y usos de las mismas |
| US12403221B2 (en) | 2021-08-06 | 2025-09-02 | Novochizol Sa | Preparation of composite gels, polymer scaffolds, aggregates and films comprising soluble cross-linked chitosan and uses thereof |
| CN114605418B (zh) * | 2022-03-15 | 2023-09-05 | 广东医科大学附属医院 | 一类具有抗肿瘤活性的依鲁替尼丙烯酰胺类衍生物及其合成方法与应用 |
| CN117430610A (zh) * | 2023-10-11 | 2024-01-23 | 宁夏医科大学 | 一种氘代稠合杂环化合物及其制备方法和应用 |
| CN117903141B (zh) * | 2023-12-19 | 2024-11-05 | 江苏长泰药业股份有限公司 | 一种化合物及其盐、在制备治疗癌症药物和激酶抑制剂中的用途、治疗癌症的药物 |
| WO2025202889A1 (en) * | 2024-03-28 | 2025-10-02 | Array Biopharma Inc. | Her2 mutation inhibitors |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040127470A1 (en) * | 1998-12-23 | 2004-07-01 | Pharmacia Corporation | Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
| GB0402143D0 (en) * | 2004-01-30 | 2004-03-03 | Smithkline Beecham Corp | Novel compounds |
| BRPI0622054B8 (pt) * | 2006-09-22 | 2021-05-25 | Oxford Amherst Llc | composto e composição farmacêutica |
| EP1921149A1 (en) | 2006-11-13 | 2008-05-14 | AEterna Zentaris GmbH | Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof |
| IL295053A (en) | 2007-03-28 | 2022-09-01 | Pharmacyclics Llc | Broton tyrosine kinase inhibitors |
| ES2660418T3 (es) * | 2008-07-16 | 2018-03-22 | Pharmacyclics Llc | Inhibidores de la tirosina quinasa de Bruton para el tratamiento de tumores sólidos |
| US7718662B1 (en) | 2009-10-12 | 2010-05-18 | Pharmacyclics, Inc. | Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase |
| CN102115476A (zh) * | 2011-03-23 | 2011-07-06 | 常州大学 | 一种2H-吡唑并[3,4-d]嘧啶衍生物及合成方法 |
| US9376438B2 (en) * | 2011-05-17 | 2016-06-28 | Principia Biopharma, Inc. | Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors |
| EA025496B1 (ru) * | 2011-05-17 | 2016-12-30 | Принсипиа Биофарма Инк. | Ингибиторы тирозинкиназы |
| US9138436B2 (en) * | 2011-07-13 | 2015-09-22 | Pharmacyclics Llc | Inhibitors of Bruton's tyrosine kinase |
| CN104487441B (zh) * | 2012-06-18 | 2018-06-01 | 普林斯匹亚生物制药公司 | 有用于治疗癌症和自身免疫性疾病的可逆的共价吡咯并嘧啶或吡唑并嘧啶 |
| CN104507946A (zh) * | 2012-07-30 | 2015-04-08 | 康塞特医药品有限公司 | 氘代依鲁替尼 |
| AU2013296509B2 (en) * | 2012-07-31 | 2017-12-21 | Orthovita Inc. | Depth controlled Jamshidi needle |
| WO2014022569A1 (en) * | 2012-08-03 | 2014-02-06 | Principia Biopharma Inc. | Treatment of dry eye |
| ME03455B (me) | 2012-09-10 | 2020-01-20 | Principia Biopharma Inc | Jedinjenja pirazolopirimidina kao inhibitori kinaze |
| US9479134B2 (en) * | 2013-03-04 | 2016-10-25 | Texas Instruments Incorporated | Position detecting system |
| WO2014143807A2 (en) | 2013-03-15 | 2014-09-18 | Stromatt Scott | Anti-cd37 antibody and bcr pathway antagonist combination therapy for treatment of b-cell malignancies and disorders |
| MX2015014171A (es) | 2013-04-08 | 2015-12-16 | Bayer Pharma AG | Uso de 2,3-dihidroimidazo[1,2-c]quinazolinas sustituidas. |
| HK1215374A1 (zh) | 2013-04-08 | 2016-08-26 | Pharmacyclics Llc | 依鲁替尼联合疗法 |
| US8957080B2 (en) * | 2013-04-09 | 2015-02-17 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
| WO2014187319A1 (en) * | 2013-05-21 | 2014-11-27 | Jiangsu Medolution Ltd | Substituted pyrazolopyrimidines as kinases inhibitors |
| CN105017256A (zh) * | 2014-04-29 | 2015-11-04 | 浙江导明医药科技有限公司 | 多氟化合物作为布鲁顿酪氨酸激酶抑制剂 |
| CN106146508A (zh) * | 2015-03-19 | 2016-11-23 | 浙江导明医药科技有限公司 | 优化的联合用药及其治疗癌症和自身免疫疾病的用途 |
-
2014
- 2014-04-29 CN CN201410175783.7A patent/CN105017256A/zh active Pending
-
2015
- 2015-04-27 EA EA201892740A patent/EA037227B1/ru unknown
- 2015-04-27 JP JP2016565402A patent/JP6670756B2/ja active Active
- 2015-04-27 AU AU2015252654A patent/AU2015252654C1/en active Active
- 2015-04-27 KR KR1020167028059A patent/KR20160144378A/ko not_active Ceased
- 2015-04-27 EA EA201692176A patent/EA032100B1/ru unknown
- 2015-04-27 ES ES15785217T patent/ES2857251T3/es active Active
- 2015-04-27 CN CN201580010345.8A patent/CN106061976B/zh active Active
- 2015-04-27 BR BR112016025132A patent/BR112016025132A2/pt not_active Application Discontinuation
- 2015-04-27 KR KR1020237032203A patent/KR102669966B1/ko active Active
- 2015-04-27 CA CA2947338A patent/CA2947338C/en active Active
- 2015-04-27 CN CN201810371229.4A patent/CN108295073B/zh active Active
- 2015-04-27 WO PCT/CN2015/000290 patent/WO2015165279A1/zh not_active Ceased
- 2015-04-27 MX MX2016014248A patent/MX387487B/es unknown
- 2015-04-27 MX MX2021013118A patent/MX2021013118A/es unknown
- 2015-04-27 EP EP15785217.9A patent/EP3138842B1/en active Active
-
2016
- 2016-03-18 US US15/075,033 patent/US9532990B2/en active Active
- 2016-10-27 IL IL248546A patent/IL248546B/en active IP Right Grant
- 2016-11-18 US US15/356,014 patent/US9861636B2/en active Active
-
2017
- 2017-11-22 US US15/820,614 patent/US10300066B2/en active Active
-
2019
- 2019-12-05 JP JP2019220363A patent/JP7005582B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017518276A5 (https=) | ||
| JP2020040989A5 (https=) | ||
| TWI883352B (zh) | 稠環化合物 | |
| KR101332585B1 (ko) | 이미다조［１，２―ａ］피라진 유도체와, 신경계, 정신과 및 대사 장애 및 질환을 예방 또는 치료하기 위한 그의 용도 | |
| JP2019048878A (ja) | Ｋｉｔに関連する疾患を治療するために有用な組成物 | |
| TWI730331B (zh) | 用於調節ｅｇｆｒ突變型激酶活性的化合物及組成物 | |
| ES2726833T3 (es) | Pirroles sustituidos activos como inhibidores de cinasas | |
| AU2012308681B2 (en) | Aminopyrimidine derivatives for use as modulators of kinase activity | |
| ME01999B (me) | Derivati pirolo[2,3-d]pirimidina kao inhibitori protein kinaze b | |
| EP2598497B1 (en) | Cyclic amine azaheterocyclic carboxamides | |
| MX361992B (es) | Compuestos de pirrolopirimidina novedosos como inhibidores de proteínas quinasas. | |
| EA201391528A1 (ru) | Ингибиторы тирозинкиназы | |
| EA201001242A1 (ru) | ПИРРОЛО[2,3-d]ПИРИДИНЫ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ТИРОЗИНКИНАЗЫ | |
| ATE493401T1 (de) | Als proteinkinaseinhibitoren geeignete diaminotriazolverbindungen | |
| EA201290147A1 (ru) | Пирроло[2,3-d]пиримидиновые соединения | |
| SG10201407409WA (en) | Inhibitors of jun n-terminal kinase | |
| EP2888247A1 (en) | Serine/threonine kinase inhibitors for the treatment of hyperproliferative!diseases | |
| CN102596961A (zh) | 咪唑并[1,2-b]哒嗪衍生物及其作为PDE10抑制剂的用途 | |
| MA37647A1 (fr) | Procédé de fabrication de composés de cyclopentapyrimidine hydroxylée et sels de ceux-ci | |
| JP2016537384A (ja) | ピロロピロロン誘導体およびｂｅｔ阻害剤としてのその使用 | |
| WO2019074810A1 (en) | INDAZOLYL-SPIRO [2,3] HEXANE-CARBONITRILE DERIVATIVES AS INHIBITORS OF LRRK2, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | |
| MA37649B1 (fr) | Procédé de fabrication de composés cyclopentylpyrimidines hydroxylées | |
| MA37751A1 (fr) | Procédé de préparation de composés d'acides aminés | |
| TN2010000363A1 (en) | Pyrrolo [2,3-d] pyridines and use thereof as tyrosine kinase inhibitors |